KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Short term Debt (2016 - 2025)

Quest Diagnostics' Short term Debt history spans 17 years, with the latest figure at $504.0 million for Q4 2025.

  • For Q4 2025, Short term Debt fell 16.28% year-over-year to $504.0 million; the TTM value through Dec 2025 reached $504.0 million, down 16.28%, while the annual FY2025 figure was $504.0 million, 16.28% down from the prior year.
  • Short term Debt for Q4 2025 was $504.0 million at Quest Diagnostics, roughly flat from $504.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $906.0 million in Q1 2024 and bottomed at $1.0 million in Q3 2021.
  • The 5-year median for Short term Debt is $152.5 million (2021), against an average of $268.6 million.
  • The largest annual shift saw Short term Debt surged 45200.0% in 2024 before it plummeted 99.89% in 2025.
  • A 5-year view of Short term Debt shows it stood at $2.0 million in 2021, then changed by 0.0% to $2.0 million in 2022, then skyrocketed by 15050.0% to $303.0 million in 2023, then soared by 98.68% to $602.0 million in 2024, then fell by 16.28% to $504.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Short term Debt are $504.0 million (Q4 2025), $504.0 million (Q3 2025), and $504.0 million (Q2 2025).